Drugs / Influenza Vaccine (Split Virion), Inactivated, Quadrivalent, ZFA02 Adjuvant
Influenza Vaccine (Split Virion), Inactivated, Quadrivalent, ZFA02 Adjuvant
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT06824519 | May → Aug 2025 overdue | influenza | Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd. | Recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Influenza Vaccine (Split Virion), Inactivated, Quadrivalent, ZFA02 Adjuvant | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06824519 ↗ |
| Modality | Vaccine | “Influenza Vaccine (Split Virion), Inactivated, Quadrivalent, ZFA02 Adjuvant” NCT06824519 ↗ |